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ABSTRACT 
Objectives: The potential benefit of growth hormone (GH) administration to increase adult height 
of normal children of short stature might be blurred by the accuracy and the precision of the 
prediction methods used to estimate final height before onset of therapy. The aim of the present 
study was to evaluate three prediction methods: Bayley-Pinneau (BP), Roche-Wainer-Thissen 
(RWT) and Tanner-Whitehouse Mark II (TW2) and to improve their accuracy and precision by 
exploring their correlation with various parameters obtained in peripubertal children with poor 
predicted adult height.  
Study Design: Accuracy and precision of the prediction methods were evaluated retrospectively by 
comparing predicted adult heights estimated in 62 boys at 13.7 ± 0.9 years and in 28 girls at 12.1 ± 
0.9 years of age, with their adult heights measured respectively at 20.7 ± 2.6 years and 18.8 ± 2.8 
years.  
Results: At the time of prediction, the height for chronological age was -2.07 ± 0.68 standard 
deviation scores for boys and -2.15 ± 0.6 years for girls. Measured adult heights were significantly 
lower than target heights (165.1 ±5.1 vs. 169.4 ± 4.8 cm for boys; p < 0.001 and 153.1 ± 3.9 vs. 156.3 ± 
5.0 cm for girls; p = 0.001). For boys, the BP method was the most accurate and also the most 
convenient with a predicted adult height of 164.7 ± 5.0 cm and a small underestimation of 0.4 ± 3.5 
cm. For girls, the TW2 method was the most accurate with a predicted height of 152.4 ± 3.7 cm with 
a little underestimation of 0.7 ±3.5 cm. There were no important differences between the precision 
of these methods. The use of a correction factor derived from the bone age delay at the time of 
prediction in boys and from the chronological age at the time of prediction in girls improved the 
accuracy of the predicted adult height.  
Conclusions: The use of a factor correcting the accuracy of the BP method in boys and of the TW2 
method in girls should be valuable in assessing the potential benefit of GH therapy to increase 
adult height in short normal children. 
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Since human growth hormone (GH) supplies became unlimited due to recombinant DNA 
technology, investigators became interested in using GH in short normal children whose GH 
secretion was otherwise normal by standard criteria. Up until now, only short-term improvement 
of growth after GH administration has been demonstrated in such “short normal” children [1-7]. To 
evaluate whether or not GH administration to “short normal” children might have increased their 
final height, investigators are comparing predicted adult height at initiation of GH therapy with the 
observed adult height. Failure to take in account the accuracy and the precision of the prediction 
methods may have blurred the potential increase of adult height of short normal children by GH 
and may explain the inconsistency of the long-term benefit of GH therapy in short normal children, 
i.e. increased final adult height [8, 27]. Therefore, the aim of the present study was to evaluate the 
accuracy and the precision of three different adult-height prediction methods: the Bayley Pinneau 
(BP) [9], the Roche-Wainer-Thissen (RWT) [10] and the Tanner-Whitehouse Mark II (TW2) methods 
[11] in a cohort of boys and girls with poor predicted adult height. Furthermore, we explored the 
possibility to improve the adult height prediction by correlating the accuracy and the precision of 
the different methods with various parameters obtained in these children at the time of prediction. 
This resulted in equations correcting the accuracy of the predictions and we propose to use these 
equations in studies designed to evaluate the effects of GH therapy on adult height of short normal 
children. 
Patients and Methods 
The medical records of children with short predicted adult height attending the outpatient 
departments of four different university centers between December 1977 and December 1986 were 
reviewed. In order to be included in the study, the children had to fulfil the following criteria when 
first evaluated: (1) a predicted adult height by the BP method below the 25th percentile for British 
standards [16]; (2) a bone age, determined by the Greulich and Pyle (GP) method [12], between 9 
and 12 years for girls, and between 11 and 14 years for boys; (3) no clinical, auxological or 
biological evidence of chronic disease, intra-uterine growth retardation, bone dysplasia, 
chromosomal aberration or endocrinopathy. At the time of prediction 67 % of the included 
children had a height at or below the 3rd percentile. 
Subjects with manifest delay of growth and puberty were excluded on the basis of the following 
criteria: stage of pubertal development < 3rd percentile according to Tanner’s criteria [13] and/or a 
bone age delay [bone age, estimated by the GP method, - chronological age] ≥ 3 years. At the time 
of follow-up, the patients were considered to have reached their final height when growing less 
than 1.5 cm during the last year and/or having reached a (near) adult bone age (≥ 99% of adult 
height attained). The chronological age at measurement of (near) final height was 20.7 ± 2.6 years 
for boys (range: 17-27 years) and 18.8 ± 2.8 years for girls (range: 15-27 years). 
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One hundred and forty four children, fulfilling the above-mentioned criteria, were contacted by 
letter and in a second phase by telephone. In all, 96 subjects came for follow-up evaluation. Finally, 
62 boys and 28 girls who reached final height were included in the study. All the subjects had 
completed their pubertal development. Of the 48 subjects lost to follow-up, the majority could not 
be traced either by letter or by telephone: 10 letters were returned because the families had moved 
and 4 patients refused to come for a follow-up consultation. The “non-responders” - one third of 
the total - did not demonstrate any significant difference in chronological age, bone age or bone 
age delay, target height, pubertal stage or predicted adult height when compared to the study 
group. 
Height was measured using a fixed Harpenden stadiometer with a precision of 0.1cm and weight 
was taken in light underclothing to the nearest 0.1 kg. Bone ages were estimated by the methods 
of GP [12] and Tanner-Whitehouse radius-ulna-short bones (TW2-RUS) [14] by the same observer 
(MV); height predictions were obtained from the tables of BP [9] and the equations of TW2 [11] and 
RWT [10]. Mid parental height was calculated from the parental heights available for 59 boys and 
27 girls; target height is defined as mid-parental height -6.5 cm for girls and +6.5 cm for boys [15]. 
Using the recently defined criteria of familial short stature, 59.3% of the boys and 55.6% of the girls 
may be classified as having familial short stature [28]. 
Standard deviation scores (SDS) or Z scores are calculated from the relationship: SDS = (x - xi)/SDi 
where x is the actual measurement, and xi and SDi are the mean and the standard deviation for the 
i-th age band of the appropriate sex, using Tanner’s standards [16]. The accuracy of the prediction 
methods was defined as the difference between the predicted and the measured adult height. A 
negative value therefore indicates underestimation of final height, whereas a positive value 
overestimation. The precision of the method is defined as the standard deviation of the accuracy 
and as the range of the accuracy for each prediction method. Results are expressed as means ± 1 
SD, unless otherwise indicated. Comparison between final and target height was performed by the 
paired t test. Bivariate linear regressions and multiple linear regressions using the forward 
selection with an F entering value ≥3.84 and a probability of ≤0.05 were performed using the 
statistical software package SPSS version 6.1 [17], A two-tailed p value of ≤0.05 was considered 
significant. 
Results 
At initial examination, the mean chronological age was 13.7 years (range: 11.7-15.3) for the boys 
and 12.1 years (10.5-13.5) for the girls (table 1). The majority of the boys (80.6%) and the girls 
(60.7%) had signs of pubertal development. The difference between mean bone age and 
chronological age was 0.4-0.5 years when bone age was assessed by the TW2-RUS method and 1-
1.5 years when determined by the GP method. Bone age retardation (GP method) ≥2 years was 
present in 15 boys (24.2%) and 8 girls (28.6%). The mean height for chronological age was -2.07 
SDS for boys and -2.15 SDS for girls, significantly lower than their respective target heights (-0.80 
and -0.99 SDS) (table 2). 
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Table 1. Characteristics of boys and girls at the time of initial examination (data are expressed as mean ± 1 SD) 
 Boys Girls 
n 62 28 
CA, years 13.7+0.9 12.1+0.9 
BA, years, GP 12.5+0.9 10.7 + 0.8 
TW2-RUS 13.4+1.0 11.6+0.9 
BA delay, GP -1.2+0.9 -1.4+0.9 
BA delay, TW2-RUS -0.4+1.0 -0.5+0.9 
Prepubertal at prediction, n 12 11 
 
CA = Chronological age; BA =bone age. 
For boys and girls, measured adult heights were significantly lower than target heights: mean 
difference for boys: -4.1 ± 5.4cm (n = 59; p < 0.001) and for girls: -3.4 ± 4.9 cm (n = 27; p = 0.001) 
(table 2). A significant proportion of boys (45.2%) had an adult height below 165 cm (~10th 
percentile) while 64.3% of the girls had an adult height under 155 cm (~10th percentile). Height in 
SDS for CA at initial presentation underestimated adult height by 30%. Using height expressed for 
bone age, estimated by the TW2-RUS method, adult height was also underestimated. In contrast, 
height expressed as SDS for bone age, determined by the method of GP, overestimated adult 
height by 0.36 ± 0.51 SDS in the boys and by 0.62 ± 0.43 SDS in the girls (table 2). These values 
correspond to a mean of 2.4 and 3.7 cm, respectively for boys and girls. 
 
Table 2. Height at the time of prediction, measured and predicted adult heights and target height. 
 
Boys Girls 
n 62 28 
Height at prediction, cm 142.2 ± 5.6 134.5 ± 4.6 
SDS for CA -2.07 ± 0.68** -2.15 ± 0.62** 
SDS for BA GP -1.09 ± 0.62** -0.89 ± 0.63** 
SDS for BA TW2-RUS -1.77 ± 0.63** -1.74 ± 0.67* 
Measured adult height, cm 165.1 ± 5.1 153.1 ± 3.9 
SDS -1.45 ± 0.78 -1.51 ± 0.64 
Target height, cm 169.4 ± 4.8 156.3 ± 5.0 
SDS -0.80 ± 0.73 -0.99 ± 0.83 
Predicted adult height, cm  
      BP 164.7 ± 5.0+ 150.4 ± 3.9** 
TW2 162.6 ± 3.90** 152.4 ± 3.7* 
RWT 165.4 ± 3.8+ 157.3 ± 3.0** 
Accuracy and precision, cm 
BP -0.4 ± 3.5 -2.8 ± 2.6 
TW2 -2.5 ± 3.5 -0.7 ± 3.5 
RWT 0.1 ± 3.5 4.4 ± 2.9 
 
Accuracy and precision of the BP, TW2, RWT methods for adult height prediction. Data are expressed as mean ± 1 SD. 
+ p > 0.05; * p < 0.05; ** p < 0.001 vs. measured adult height by paired t test. CA = Chronological age; BA = bone age. 
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For each method, predicted adult height was highly and significantly correlated with the measured 
adult height (table 3) for boys and girls. For both sexes, the highest correlation coefficients were 
obtained with the BP method. 
 
Table 3. Linear regression of predicted adult height (cm) on measured adult height (cm) using the BP, TW2 and 







SE of the 
regression 
coefficient 
Constant SD of the 
residuals 
Boys 
     
BP 0.76 0.74 0.08 42.4    3.2 
TW-2 0.74 0.56 0.07 70.4    2.6 
RWT 0.70 0.54 0.07 75.5    2.7 
Girls      
BP 0.78 0.77 0.12 32.3    2.5 
TW-2 0.58 0.55 0.15 68.6    3.0 
RWT 0.66 0.53 0.12 75.6 2.3 
 
For all the regression coefficients, p < 0.001. 
For boys, the most accurate methods of adult height prediction were the RWT and the BP methods: 
the BP slightly underestimated while the RWT slightly overestimated final height (table 2). In 
contrast, the TW2 method underestimated adult height by a mean of 2.5 ± 3.5 cm. The precision of 
the three methods was similar as demonstrated by the SD as well as the ranges of their respective 
accuracy: BP: 3.5 and -7.8 to +7.9 cm; RWT: 3.5 and -7.2 to +8.7 cm; TW2: 3.45 and -9.3 to +4.3 cm. 
To determine which variable obtained at the time of prediction correlated with the accuracy of the 
different prediction methods, bivariate linear regressions were obtained between accuracy for 
each method and the following variables at initial examination: chronological age, bone age, bone 
age delay, height in SDS for chronological age or bone age and target height SDS. Only the 
significant correlations are shown for boys in table 4. For the TW2 prediction method, no 
significant correlations were found. The strongest correlation was obtained for the BP method 
between accuracy and bone age delay observed at the initial examination (table 4, fig. 1). Using 
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Fig. 1. Correlation between the accuracy of the BP method of adult height prediction and bone age delay at the 
time of final height prediction in boys (accuracy = -1.95-1.24 x bone age delay; R = -0.34; p = 0.008; SD of the 

















SE of the 
regression 
coefficient 
Constant SD of the 
residuals 
Bayley Pinneau 
BA -0.31 0.016 -1.16 0.47 14.14 3.33 
BA delay -0.34 0.008 -1.24 0.45 -1.95 3.29 
Height SDS for BA 0.26 0.039 1.47 0.69  1.19 3.37 
Roche- Wainer-Thissen 
Target height SDS 0.25 0.05 1.20 0.61 1.09 3.38 
 
BA = Bone age. 
For the girls, the TW2 method was the most accurate, underestimating final height by 0.7 ± 3.5 cm 
(table 2). The RWT method grossly overestimated by 4.4 cm while the BP underestimated adult 
height by a mean of 2.8 cm. The precision was slightly better for the BP method (SD: 2.6 and range -
9.6 to +1.6 cm), followed by the RWT method (SD: 2.9 and range: -1.3 to 10.4 cm) and the TW2 
method (SD: 3.5 and range: -7.8 to 5.4 cm). Significant bivariate linear correlations between the 
accuracy of each method and the variables obtained at initial examination could only be found for 
the TW2 method of prediction. The strongest correlation was observed for chronological age (table 
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Fig. 2. Correlation between the accuracy of the TW2 method of prediction of adult height prediction and 
chronological age at the time of final height prediction in girls (accuracy = 21.97 - 1.87 x chronological age; R = -


















SE of the 
regression 
coefficient 
Constant SD of the 
residuals 
Tanner-Whitehouse 2       
CA -0.50 0.007 -1.87 0.63 21.97 3.05 
BA -0.42 0.025 -1.61 0.67 18.03 3.19 
Height SDS for CA  0.42 0.025 2.36 0.99    4.33 3.19 
 
CA = Chronological age; BA = bone age. 
Discussion 
Several studies have been published on the effects of GH administration on the growth of children 
of short stature of predominantly familial origin with normal GH secretion [1-7, 27]. The evaluation 
of the effect of such therapy on final height is based upon the observed difference between 
predicted adult height before therapy and attained adult height at the end of therapy. This presup-
poses that the methods of adult height prediction are sufficiently accurate and precise not to 
obscure the eventual effects of GH therapy. Studies evaluating different prediction methods have 
been reported recently [18-25] but have focused almost exclusively on short children with 
constitutional delay of growth and puberty. In the present study, most of the children had short 
parents and no major delay in bone maturation, suggesting that their short stature was of familial 
origin without an important component of constitutional delay. The data available from the 
Published in: Hormone Research (1997), vol. 48, n°4, pp. 184–190 
DOI: 10.1159/000185511 




literature on the accuracy of the different prediction methods, together with the findings of the 
present study, are presented in table 6. 
 
Table 6. Accuracy (cm) of prediction methods of previously reported and present study. 
 BP TW2 RWT Subjects (n) 
Boys     
Blethen et al. [18] -1.6 NA NA 171 
 + 3.0 NA NA 102 
Joss etal. [19] +3.3 +2.3 +2.6 132 
Crowne et al. [20] NA +2.0 NA 432 
Willigetal. [21] +0.8 -6.0 +1.0 772 
La Franchi et al. [22] +1.9 NA +0.1 292 
Bramswig et al. [23] +3.1 -4.2 -0.5 372 
Spcrlich et al. [24] +0.2 -3.5 -1.4 492 
Holletal. [25] + 1.0 -3.0 -0.1 882 
Present study -0.4 -2.5 +0.1 621 
Girls     
Joss et al. [19] -0.3 +3.9 +6.3    92 
La Franchi et al. [22] -0.8 NA +3.7 132 
Bramswig et al. [23] -0.8 -1.8 +2.6 322 
Present study -2.8 -0.7 +4.4 281 
 
NA = not available. 
1 Bone age slightly or not delayed. 
2 Bone age constantly delayed. 
 
From our data in boys, the BP and the RWT methods appear to be the most accurate methods, 
while the TW2 method tended to underpredict final height. With the exception of the data reported 
by Crowne et al. [20] and Joss et al. [ 19] – the latter studying only a very small number of subjects,  
underprediction of final height by the TW2 method has been a constant finding for boys with 
constitutional delay of growth and puberty [21-25]. This underprediction varies from 3 cm in the 
study by Holl et al. [25] to a maximum of 6 cm in the study reported by Willig et al. [21]. These 
figures are greater than the underestimation we observed by the same method in boys, who 
presented with no major delay in bone age, however. In this respect, it should be realized that the 
magnitude of the underprediction by the TW2 method is correlated with the age at onset and the 
intensity of the adolescent growth spurt [26]. Therefore, the different values reported might be 
related to the different timings in the onset of the pubertal growth spurt and/or the importance of 
the pubertal growth acceleration. Differences in the proportion of children in puberty at the time of 
height prediction included in the different studies might also explain the differences in the 
reported accuracy and precision of the prediction methods. 
In our study, as for the 17 boys reported by Blethen et al. [18] in whom bone age delay was minimal 
or absent, there was a tendency to a slight underestimation of adult height with the BP method. On 
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the other hand, in studies where boys had a rather important delay in bone maturation [19, 21-25] 
an overestimation of final height was reported, varying from only 0.2 cm [24] to more than 3 cm 
[19, 23]. These differences fit very well with the inverse correlation we have observed between the 
accuracy of the BP method and the bone age delay at the time of prediction, i.e. with a greater 
bone age delay, the BP method tended to overestimate adult height. 
The precision of the three methods was equivalent as assessed by their SDs and the ranges of the 
accuracy. The error or the accuracy of the BP method could be improved when correlated with the 
bone age delay measured at the time of prediction and can therefore be used as a correcting factor 
for the predicted adult height prior to comparison with measured adult height. 
Our data in girls suggest that the most accurate method is that of TW2, where only a slight 
underprediction was observed. Underprediction was also found in the study of Bramswig et al. [23] 
in a subset of short girls with mixed constitutional delay and familial short stature, whereas Joss et 
al. [19] observed the contrary, however in a very small population. Since accuracy of the TW2 
method is inversely correlated to chronological age at the time of prediction, differences of this 
variable might explain the divergent results obtained. In our study, no important differences 
between the precisions of the three methods could be found. Since there is a significant inverse 
correlation between the accuracy of the TW2 method and the chronological age at prediction, we 
propose that the predicted adult height estimated by the TW2 method should be corrected by a 
factor derived from the regression equation between these 2 variables before comparison with 
adult height. 
Underestimation by the BP method and gross overestimation of adult height by the RWT method 
as reported in the present study is in accordance with the results of other studies [19, 22, 23]. 
Nevertheless, the limited number of observations available in girls must warrant some caution in 
drawing definite conclusions. In addition, the extrapolation of the amendments that we propose 
for improving the accuracy of the prediction of final heights in boys and girls to short normal 
children of younger ages than the ones we have studied should await additional studies. 
With the use of the BP prediction method in boys and the TW2 method in girls, we have at our 
disposal a fairly reliable way of evaluating the growth-promoting effects of GH therapy in short 
normal children. However, the still large individual confidence intervals implicate that a large 
population of treated children should be studied. Therefore, the inclusion of untreated control 
subjects, carefully matched to treated subjects, might still be additionally necessary, in order to 
correctly assess the effects of growth-promoting therapies in “short normal” children. 
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